erdosteine

Small moleculeexperimental

Erdosteine is a molecule with mucolytic activity. Structurally it is a thioether derivative with two thioether groups. These two functional organosulfur groups contained in the molecule are released following first-pass metabolism with the conversion of erdosteine into its pharmacologically active metabolite Met-I (N-thiodiglycolyl-homocysteine). — Wikipedia

Clinical trial activity

5 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
2

Earliest trial started Mar 1, 2006 (NCT00338507)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2009

    Earliest Phase 3 Sponsor(trial)

2010s

  1. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetOTHER

    Anti-inflammatory, anti-oxidant

  • Unspecified targetOTHER

    Expectorant

  • Unspecified targetAntioxidant

    Antioxidant

Chemistry & pharmacology

Loading structure…

SMILES

O=C(O)CSCC(=O)NC1CCSC1=O
Mol. weight
249.31 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • dithiosteine
  • dostein
  • edirel
  • erdosteine
  • erdosteine
  • erdosteine
  • erdosteine
  • erdosteine
  • erdosteine
  • erdosteine
  • erdosteine
  • esteclin
  • rv 144
  • rv-144
  • s-(2-(n-3-(2-oxo-tetrahydrothienyl)acetamido))thioglycolic acid
  • vectrine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06038084Phase 4Apr 15, 2022Hanlim Pharm. Co., Ltd., Konkuk University
NCT02332044Phase 1Apr 1, 2014Daewoong Pharmaceutical Co. LTD.
NCT01176318Phase 4Aug 4, 2010Galen, University of Hull
NCT01032304Phase 3Aug 1, 2009Recipharm
NCT00338507Phase 2Mar 1, 2006Adams Respiratory Therapeutics
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Adams Respiratory TherapeuticsFor profit1112006
Daewoong Pharmaceutical Co. LTD.For profit1112014
GalenFor profit1012010
Hanlim Pharm. Co., Ltd.For profit1012022
Konkuk UniversityAcademic/Hospital1112022
RecipharmFor profit1112009
University of HullAcademic/Hospital1112010
7 organizations
Page 1 / 1